According to Future Market Insights (FMI), the demand for pharmaceutical caps and closures is expected to rise considerably, enabling the market to surpass US$ 2.27 Bn in valuation by the end of 2021.
Continuous advancements in research and development for drug supplements is a key factor speeding up packaging innovations. Advanced technologies used in packaging primarily focus on ensuring stability of drugs during storage, shipment, and delivery.
In the coming years, the rising cases of chronic disease will support the expansion of the market. The role of smart packaging for medication is increasing to offer greater precision of administered medication, which directly affects patient compliance. This will influence the adoption of cost-effective yet advanced packaging solutions among manufacturers.
The pharmaceutical caps and closures market will therefore register adoption of digital manufacturing. This technology offers high quality caps and closure, with minimal time and cost requirements.
Focus on reducing product damage by user has encouraged inventors to introduce multi-dose delivery caps. The product’s user can remove fluid from the vial by interfacing a needle to the cap. The smart cap ensures that leftover fluid is clean.
In the past few years, environmental awareness among consumers has increased the need for sustainable packaging. In pharmaceutical packaging, the primary concern is product stability.
The demand for reducing the risk of cross contamination of product drives the use of biodegradable material in caps and closures. Also, waste product management is a key concern. Environmentally-friendly material produce lesser waste and are also recyclable.
Despite this, plastics remain the preferred material for manufacturing caps and closures. Plastic use in the market is expected to rise at 6.4% as producers aim for greater flexibility.
To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13237
Key Takeaways from Pharmaceutical caps and closures Services Market Study
- Despite restricted growth amid COVID-19, the demand for pharmaceutical caps and closures is expected to rise at nearly 5% CAGR in 2021.
- Increasing focus on light weight packaging is driving a transition towards resin-based packaging material.
- The U.K. and Germany are leading markets in Europe, accounting for more than 26% and 17% of the Europe market respectively in 2021
- The U.S. will account for a dominant share of 89% in the North America market through the forecast period.
- China is the largest and fastest growing market in East Asia, exhibiting 8% CAGR through 2031.
“Increasing demand for smart and safe packaging solutions for pharmaceuticals, besides favorable reimbursement policies will offer lucrative growth opportunities for pharmaceutical caps and closure manufacturers through the assessment period in 2031,” says the FMI analyst.
Increase in Funding for Research Activities Offers Growth OpportunitiesLeading manufacturers in the pharmaceutical caps and closures market are strengthening their market position through collaboration with various other organizations. Governments in developed and developing countries are actively taking initiatives to encourage research pharmaceutical packaging products.
For instance, Voltaren “No Mess” applicator from GSK Consumer Health was co-developed with Neopac and Nypro Healthcare.
Big drug producers are expected to benefit from the globalization of labor forces, that is, employment of skilled local labor at cheaper rates to derive larger cost savings. Furthermore, this will create room for research and development (R&D) investments.
As per data from EFPIA and PhRMA, annual pharmaceutical (R&D) expenditures increased at 2.5% p.a. in Europe as compared to 3.3% p.a. in the U.S. over the latest measurable period 2016-2020. This will also create opportunities for the expansion of the market.
Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13237
Who is winning?The global market is set to expand due to the rising prevalence of chronic diseases. Leading organizations within the market are set to focus on research and development to offer an early and precise diagnosis of the ailment, besides offering effective patient care.
Some of the leading players in the pharmaceutical caps and closures market include but are not limited to Berry Global Inc., Amcor Plc, Aptar Inc., Closure Systems International Inc., O.Berk Company LLC, Bericap GmbH and Co KG, UNITED CAPS, CL Smith Company, Georg MENSHEN GmbH & Co. KG, WestRock Company, West Pharmaceutical Services Inc., Drug Plastics and Glass Co Inc., Gerresheimer AG, DWK Life Sciences GmbH, Parekhplast India Limited, and Parshva Exim Limited.
Want more insights?Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global pharmaceutical caps and closures market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the pharmaceutical caps and closures treatment market on basis of the main indication in detail, cover every aspect of the market such as product type, molecule type, application, and service provider across seven major regions.
Phramacutical caps and Closures Services Market by CategoryProduct type
- Screw Caps & Closure
- Snap Caps & Closure
- Push-Pull Caps & Closure
- Stopper & Seals
- Others
Functionality
- Child Resistant
- Tamper-evident
Material type
- Plastic
- Elastomer
- Metal
Avalability
- Prescription (Rx) Pharmaceuticals
- “Over-the-Counter (OTC) Pharmaceuticals”
Drug Modality
- Small Molecule (Synthetic Drugs)
- Biopharmaceuticals
Therapeutic class
- Anticancer Drugs
- Anti-infective Drugs
- Anti-viral Drugs
- Anti-bacterial Drugs
- Anti-fungal Drugs
- Others
- Cardiovascular Drugs
- Anti-inflammatory Drugs
- Analgesics Drugs
- Anti-diabetics
- Ophthalmic Drugs
- Neurological Drugs
- Others
End Users
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMO)
- Contract Research Organizations (CRO)
- Academic & Research Institutes
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13237
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
Website: https://www.futuremarketinsights.com/
